Company intelligence / Profile preview

Eurazeo

Paris, France

Ownership: Private
Employees: ~400
Development stage: Other

Overview

Eurazeo is a leading European private equity and investment firm with a major focus on growth, buyout, and venture investments across multiple sectors, including a significant commitment to healthcare, biotech, and medtech via its dedicated funds and subsidiaries. It acts as an investor and fund manager, not an operating company, backing emerging healthcare leaders and technologies from early venture to late-stage growth.

Industry: Investors

Partnerships

Kurma PartnersNov Santé Actions Non CotéesPortfolio alliances with multiple healthcare companies (e.g., PanTera, Germitec, Oncodesign, Kinvest)

Beyond the preview

Go deeper on Eurazeo.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eurazeo.

Explore the full profile